​

Takeda Pharmaceutical (TAK) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

TAK Stock Rating

Takeda Pharmaceutical stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 5 Strong Sell Sell Hold Buy Strong Buy

TAK Price Target Upside V Benchmarks

TypeNameUpside
StockTakeda Pharmaceutical-
SectorHealthcare Stocks 23.68%
IndustrySpecialty & Generic Drug Manufacturers Stocks28.78%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$15.39$15.39$15.39
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25-31--4
May, 25-31--4
Apr, 25-31--4
Mar, 25-31--4
Feb, 25-31--4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 02, 2025Morgan StanleyOverweightupgrade
Sep 10, 2024Johnson RiceBuyinitialise
Jul 24, 2024GuggenheimBuyinitialise
Jul 09, 2024Goldman SachsNeutralNeutralhold
Apr 04, 2023Cowen & Co.OutperformOutperformhold
Mar 16, 2023Bank of America SecuritiesBuyupgrade
Jul 19, 2022Cowen & Co.Outperformupgrade

Financial Forecast

EPS Forecast

$0 $50 $100 $150 $200 $250 Mar 21 Mar 22 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29 Mar 30
Mar 21Mar 22Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29Mar 30
Reported$240.72$147.14$92.09------
Avg Forecast$85.99$75.36$100.23$44.62$41.59$74.60$98.84$130.73$151.39
High Forecast$87.33$76.54$105.28$46.70$42.66$77.76$103.82$137.32$159.01
Low Forecast$84.65$74.19$95.96$43.13$39.98$68.27$94.63$125.17$144.94
Surprise %179.94%95.25%-8.12%------

Revenue Forecast

$3T $4T $4T $5T $5T $6T Mar 21 Mar 22 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29 Mar 30
Mar 21Mar 22Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29Mar 30
Reported$3.20T$3.57T$4.26T------
Avg Forecast$3.27T$3.49T$3.98T$4.11T$4.66T$4.65T$4.72T$4.86T$5.03T
High Forecast$3.31T$3.53T$4.13T$4.16T$4.67T$4.69T$4.91T$5.05T$5.22T
Low Forecast$3.24T$3.45T$3.85T$4.07T$4.66T$4.60T$4.57T$4.70T$4.86T
Surprise %-2.35%2.25%7.11%------

Net Income Forecast

$50B $120B $190B $260B $330B $400B Mar 21 Mar 22 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29 Mar 30
Mar 21Mar 22Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29Mar 30
Reported$376.00B$230.06B$144.07B------
Avg Forecast$135.89B$119.10B$158.40B$70.51B$65.72B$117.89B$156.20B$206.60B$239.24B
High Forecast$138.01B$120.96B$166.37B$73.80B$67.42B$122.89B$164.06B$217.01B$251.29B
Low Forecast$133.77B$117.24B$151.65B$68.16B$63.18B$107.89B$149.55B$197.80B$229.05B
Surprise %176.70%93.16%-9.05%------

TAK Forecast FAQ

Is Takeda Pharmaceutical stock a buy?

Takeda Pharmaceutical stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Takeda Pharmaceutical is a favorable investment for most analysts.

What is Takeda Pharmaceutical's price target?

Takeda Pharmaceutical's price target, set by 5 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $15.39.

How does Takeda Pharmaceutical stock forecast compare to its benchmarks?

Takeda Pharmaceutical's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (23.68%) and underperforming the specialty & generic drug manufacturers stocks industry (28.78%).

What is the breakdown of analyst ratings for Takeda Pharmaceutical over the past three months?

  • June 2025: 0% Strong Buy, 75.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 75.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 0% Strong Buy, 75.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.

What is Takeda Pharmaceutical’s EPS forecast?

Takeda Pharmaceutical's average annual EPS forecast for its fiscal year ending in March 2025 is $44.62, marking a -51.55% decrease from the reported $92.09 in 2024. Estimates for the following years are $41.59 in 2026, $74.6 in 2027, $98.84 in 2028, $130.73 in 2029, and $151.39 in 2030.

What is Takeda Pharmaceutical’s revenue forecast?

Takeda Pharmaceutical's average annual revenue forecast for its fiscal year ending in March 2025 is $4.11T, reflecting a -3.51% decrease from the reported $4.26T in 2024. The forecast for 2026 is $4.66T, followed by $4.65T for 2027, $4.72T for 2028, $4.86T for 2029, and $5.03T for 2030.

What is Takeda Pharmaceutical’s net income forecast?

Takeda Pharmaceutical's net income forecast for the fiscal year ending in March 2025 stands at $70.51B, representing a -51.06% decrease from the reported $144.07B in 2024. Projections indicate $65.72B in 2026, $117.89B in 2027, $156.2B in 2028, $206.6B in 2029, and $239.24B in 2030.